{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:31:15Z","timestamp":1791279075995,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,5,29]]},"DOI":"10.1038\/onc.2013.249","type":"journal-article","created":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T10:50:24Z","timestamp":1374490224000},"page":"2898-2908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["CD82\/KAI expression prevents IL-8-mediated endothelial gap formation in late-stage melanomas"],"prefix":"10.1038","volume":"33","author":[{"given":"P","family":"Khanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-Y","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R I","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G P","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,22]]},"reference":[{"key":"BFonc2013249_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nature05661","volume":"445","author":"V Gray-Schopfer","year":"2007","unstructured":"Gray-Schopfer V, Wellbrock C, Marais R . Melanoma biology and new targeted therapy. Nature 2007; 445: 851\u2013857.","journal-title":"Nature"},{"key":"BFonc2013249_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3835(03)00304-5","volume":"198","author":"LA Shevde","year":"2003","unstructured":"Shevde LA, Welch DR . Metastasis suppressor pathways\u2014an evolving paradigm. Cancer Lett 2003; 198: 1\u201320.","journal-title":"Cancer Lett"},{"key":"BFonc2013249_CR3","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1056\/NEJMra0805239","volume":"359","author":"AC Chiang","year":"2008","unstructured":"Chiang AC, Massague J . Molecular basis of metastasis. N Engl J Med 2008; 359: 2814\u20132823.","journal-title":"N Engl J Med"},{"key":"BFonc2013249_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0190-9622(92)70146-7","volume":"27","author":"DG Brodland","year":"1992","unstructured":"Brodland DG, Zitelli JA . Mechanisms of metastasis. J Am Acad Dermatol 1992; 27: 1\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"BFonc2013249_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/30.3.7061823","volume":"30","author":"GL Nicolson","year":"1982","unstructured":"Nicolson GL . Metastatic tumor cell attachment and invasion assay utilizing vascular endothelial cell monolayers. J Histochem Cytochem 1982; 30: 214\u2013220.","journal-title":"J Histochem Cytochem"},{"key":"BFonc2013249_CR6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cyto.2008.07.014","volume":"43","author":"G Germano","year":"2008","unstructured":"Germano G, Allavena P, Mantovani A . Cytokines as a key component of cancer-related inflammation. Cytokine 2008; 43: 374\u2013379.","journal-title":"Cytokine"},{"key":"BFonc2013249_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/jcp.20647","volume":"208","author":"K Nagasawa","year":"2006","unstructured":"Nagasawa K, Chiba H, Fujita H, Kojima T, Saito T, Endo T et al. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J Cell Physiol 2006; 208: 123\u2013132.","journal-title":"J Cell Physiol"},{"key":"BFonc2013249_CR8","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1016\/j.febslet.2011.08.031","volume":"585","author":"YC Tsai","year":"2011","unstructured":"Tsai YC, Weissman AM . Dissecting the diverse functions of the metastasis suppressor CD82\/KAI1. FEBS Lett 2011; 585: 3166\u20133173.","journal-title":"FEBS Lett"},{"key":"BFonc2013249_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/path.2779","volume":"223","author":"HM Romanska","year":"2011","unstructured":"Romanska HM, Berditchevski F . Tetraspanins in human epithelial malignancies. J Pathol 2011; 223: 4\u201314.","journal-title":"J Pathol"},{"key":"BFonc2013249_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4161\/cib.1.1.6406","volume":"1","author":"K Singethan","year":"2008","unstructured":"Singethan K, Schneider-Schaulies J . Tetraspanins: small transmembrane proteins with big impact on membrane microdomain structures. Commun Integr Biol 2008; 1: 11\u201313.","journal-title":"Commun Integr Biol"},{"key":"BFonc2013249_CR11","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1096\/fj.08-123414","volume":"23","author":"C Xu","year":"2009","unstructured":"Xu C, Zhang YH, Thangavel M, Richardson MM, Liu L, Zhou B et al. CD82 endocytosis and cholesterol-dependent reorganization of tetraspanin webs and lipid rafts. FASEB J 2009; 23: 3273\u20133288.","journal-title":"FASEB J"},{"key":"BFonc2013249_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrc2543","volume":"9","author":"M Zoller","year":"2009","unstructured":"Zoller M . Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009; 9: 40\u201355.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2013249_CR13","doi-asserted-by":"publisher","first-page":"e51797","DOI":"10.1371\/journal.pone.0051797","volume":"7","author":"WM Liu","year":"2012","unstructured":"Liu WM, Zhang F, Moshiach S, Zhou B, Huang C, Srinivasan K et al. Tetraspanin CD82 inhibits protrusion and retraction in cell movement by attenuating the plasma membrane-dependent actin organization. PLoS One 2012; 7: e51797.","journal-title":"PLoS One"},{"key":"BFonc2013249_CR14","first-page":"707","volume":"15","author":"WU Shiwu","year":"2012","unstructured":"Shiwu WU, Lan Y, Wenqing S, Lei Z, Yisheng T . Expression and clinical significance of CD82\/KAI1 and E-cadherin in non-small cell lung cancer. Arch Iran Med 2012; 15: 707\u2013712.","journal-title":"Arch Iran Med"},{"key":"BFonc2013249_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1349-7006.1998.tb00577.x","volume":"89","author":"A Takaoka","year":"1998","unstructured":"Takaoka A, Hinoda Y, Sato S, Itoh F, Adachi M, Hareyama M et al. Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells. Jpn J Cancer Res 1998; 89: 397\u2013404.","journal-title":"Jpn J Cancer Res"},{"key":"BFonc2013249_CR16","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nm1444","volume":"12","author":"S Bandyopadhyay","year":"2006","unstructured":"Bandyopadhyay S, Zhan R, Chaudhuri A, Watabe M, Pai SK, Hirota S et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med 2006; 12: 933\u2013938.","journal-title":"Nat Med"},{"key":"BFonc2013249_CR17","first-page":"5724","volume":"59","author":"DP Lombardi","year":"1999","unstructured":"Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC . Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res 1999; 59: 5724\u20135731.","journal-title":"Cancer Res"},{"key":"BFonc2013249_CR18","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.cell.2008.03.038","volume":"133","author":"JC Acosta","year":"2008","unstructured":"Acosta JC, O\u2019Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008; 133: 1006\u20131018.","journal-title":"Cell"},{"key":"BFonc2013249_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1158\/0008-5472.CAN-08-3378","volume":"69","author":"S Singh","year":"2009","unstructured":"Singh S, Varney M, Singh RK . Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis. Cancer Res 2009; 69: 411\u2013415.","journal-title":"Cancer Res"},{"key":"BFonc2013249_CR20","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.ejca.2009.07.007","volume":"45","author":"C Gabellini","year":"2009","unstructured":"Gabellini C, Trisciuoglio D, Desideri M, Candiloro A, Ragazzoni Y, Orlandi A et al. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Eur J Cancer 2009; 45: 2618\u20132627.","journal-title":"Eur J Cancer"},{"key":"BFonc2013249_CR21","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1084\/jem.181.4.1311","volume":"181","author":"SC Peiper","year":"1995","unstructured":"Peiper SC, Wang ZX, Neote K, Martin AW, Showell HJ, Conklyn MJ et al. The Duffy antigen\/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995; 181: 1311\u20131317.","journal-title":"J Exp Med"},{"key":"BFonc2013249_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/pro.5560060310","volume":"6","author":"SR Leong","year":"1997","unstructured":"Leong SR, Lowman HB, Liu J, Shire S, Deforge LE, Gillece-Castro BL et al. IL-8 single-chain homodimers and heterodimers: interactions with chemokine receptors CXCR1, CXCR2, and DARC. Protein Sci 1997; 6: 609\u2013617.","journal-title":"Protein Sci"},{"key":"BFonc2013249_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ccr.2006.08.012","volume":"10","author":"A Zijlstra","year":"2006","unstructured":"Zijlstra A, Quigley JP . The DARC side of metastasis: shining a light on KAI1-mediated metastasis suppression in the vascular tunnel. Cancer Cell 2006; 10: 177\u2013178.","journal-title":"Cancer Cell"},{"key":"BFonc2013249_CR24","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1158\/0008-5472.CAN-06-3801","volume":"67","author":"M Iiizumi","year":"2007","unstructured":"Iiizumi M, Bandyopadhyay S, Watabe K . Interaction of Duffy antigen receptor for chemokines and KAI1: a critical step in metastasis suppression. Cancer Res 2007; 67: 1411\u20131414.","journal-title":"Cancer Res"},{"key":"BFonc2013249_CR25","doi-asserted-by":"publisher","first-page":"L462","DOI":"10.1152\/ajplung.00224.2009","volume":"298","author":"A Zarbock","year":"2010","unstructured":"Zarbock A, Bishop J, Muller H, Schmolke M, Buschmann K, Van Aken H et al. Chemokine homeostasis vs. chemokine presentation during severe acute lung injury: the other side of the Duffy antigen receptor for chemokines. Am J Physiol Lung Cell Mol Physiol 2010; 298: L462\u2013L471.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFonc2013249_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12195-008-0016-8","volume":"1","author":"S Liang","year":"2008","unstructured":"Liang S, Hoskins M, Khanna P, Kunz RF, Dong C . Effects of the tumor\u2013leukocyte microenvironment on melanoma\u2013neutrophil adhesion to the endothelium in a shear flow. Cell Mol Bioeng 2008; 1: 189\u2013200.","journal-title":"Cell Mol Bioeng"},{"key":"BFonc2013249_CR27","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.yexcr.2006.10.030","volume":"313","author":"HH Peng","year":"2007","unstructured":"Peng HH, Liang S, Henderson AJ, Dong C . Regulation of interleukin-8 expression in melanoma-stimulated neutrophil inflammatory response. Exp Cell Res 2007; 313: 551\u2013559.","journal-title":"Exp Cell Res"},{"key":"BFonc2013249_CR28","first-page":"145","volume":"2","author":"C Dong","year":"2005","unstructured":"Dong C, Slattery MJ, Liang S, Peng HH . Melanoma cell extravasation under flow conditions is modulated by leukocytes and endogenously produced interleukin 8. Mol Cell Biomech 2005; 2: 145\u2013159.","journal-title":"Mol Cell Biomech"},{"key":"BFonc2013249_CR29","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","volume":"14","author":"DJ Waugh","year":"2008","unstructured":"Waugh DJ, Wilson C . The interleukin-8 pathway in cancer. Clin Cancer Res 2008; 14: 6735\u20136741.","journal-title":"Clin Cancer Res"},{"key":"BFonc2013249_CR30","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","volume":"170","author":"A Li","year":"2003","unstructured":"Li A, Dubey S, Varney ML, Dave BJ, Singh RK . IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003; 170: 3369\u20133376.","journal-title":"J Immunol"},{"key":"BFonc2013249_CR31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F . Cancer-related inflammation. Nature 2008; 454: 436\u2013444.","journal-title":"Nature"},{"key":"BFonc2013249_CR32","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1006\/cyto.1998.0465","volume":"11","author":"C Murdoch","year":"1999","unstructured":"Murdoch C, Monk PN, Finn A . Cxc chemokine receptor expression on human endothelial cells. Cytokine 1999; 11: 704\u2013712.","journal-title":"Cytokine"},{"key":"BFonc2013249_CR33","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1182\/blood-2004-06-2246","volume":"105","author":"ML Criscuoli","year":"2005","unstructured":"Criscuoli ML, Nguyen M, Eliceiri BP . Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. Blood 2005; 105: 1508\u20131514.","journal-title":"Blood"},{"key":"BFonc2013249_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1006\/excr.1999.4601","volume":"252","author":"E Dejana","year":"1999","unstructured":"Dejana E, Bazzoni G, Lampugnani MG . Vascular endothelial (VE)-cadherin: only an intercellular glue? Exp Cell Res 1999; 252: 13\u201319.","journal-title":"Exp Cell Res"},{"key":"BFonc2013249_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.febslet.2008.11.032","volume":"583","author":"J Gavard","year":"2009","unstructured":"Gavard J . Breaking the VE-cadherin bonds. FEBS Lett 2009; 583: 1\u20136.","journal-title":"FEBS Lett"},{"key":"BFonc2013249_CR36","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2741\/1643","volume":"10","author":"HH Peng","year":"2005","unstructured":"Peng HH, Hodgson L, Henderson AJ, Dong C . Involvement of phospholipase C signaling in melanoma cell-induced endothelial junction disassembly. Front Biosci 2005; 10: 1597\u20131606.","journal-title":"Front Biosci"},{"key":"BFonc2013249_CR37","doi-asserted-by":"publisher","first-page":"C1140","DOI":"10.1152\/ajpcell.00242.2009","volume":"298","author":"P Khanna","year":"2010","unstructured":"Khanna P, Yunkunis T, Muddana HS, Peng HH, August A, Dong C . p38 MAP kinase is necessary for melanoma-mediated regulation of VE-cadherin disassembly. Am J Physiol Cell Physiol 2010; 298: C1140\u2013C1150.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"Partt 1","key":"BFonc2013249_CR38","first-page":"L99","volume":"269","author":"AD Verin","year":"1995","unstructured":"Verin AD, Patterson CE, Day MA, Garcia JG . Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am J Physiol 1995; 269 (Partt 1): L99\u2013108.","journal-title":"Am J Physiol"},{"key":"BFonc2013249_CR39","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1158\/0008-5472.CAN-08-3772","volume":"69","author":"JC Acosta","year":"2009","unstructured":"Acosta JC, Gil J . A role for CXCR2 in senescence, but what about in cancer? Cancer Res 2009; 69: 2167\u20132170.","journal-title":"Cancer Res"},{"key":"BFonc2013249_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-4598-8-3","volume":"8","author":"ME Lleonart","year":"2009","unstructured":"Lleonart ME, Artero-Castro A, Kondoh H . Senescence induction: a possible cancer therapy. Mol Cancer 2009; 8: 3.","journal-title":"Mol Cancer"},{"key":"BFonc2013249_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1158\/1541-7786.MCR-10-0511","volume":"9","author":"T Fan","year":"2011","unstructured":"Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CC et al. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21\/CDKN1A expression. Mol Cancer Res 2011; 9: 418\u2013429.","journal-title":"Mol Cancer Res"},{"key":"BFonc2013249_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1755-148X.2010.00820.x","volume":"24","author":"S Giuliano","year":"2011","unstructured":"Giuliano S, Ohanna M, Ballotti R, Bertolotto C . Advances in melanoma senescence and potential clinical application. Pigment Cell Melanoma Res 2011; 24: 295\u2013308.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFonc2013249_CR43","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.canlet.2009.05.038","volume":"286","author":"S Liu","year":"2009","unstructured":"Liu S, Yamauchi H . p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function. Cancer Lett 2009; 286: 240\u2013249.","journal-title":"Cancer Lett"},{"key":"BFonc2013249_CR44","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/jid.2008.214","volume":"129","author":"R Houben","year":"2009","unstructured":"Houben R, Ortmann S, Drasche A, Troppmair J, Herold MJ, Becker JC . Proliferation arrest in B-Raf mutant melanoma cell lines upon MAPK pathway activation. J Invest Dermatol 2009; 129: 406\u2013414.","journal-title":"J Invest Dermatol"},{"key":"BFonc2013249_CR45","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3181\/00379727-213-44046","volume":"213","author":"AL Gartel","year":"1996","unstructured":"Gartel AL, Serfas MS, Tyner AL . p21-Negative regulator of the cell cycle. Proc Soc Exp Biol Med 1996; 213: 138\u2013149.","journal-title":"Proc Soc Exp Biol Med"},{"key":"BFonc2013249_CR46","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/S0962-8924(01)82148-6","volume":"11","author":"J Campisi","year":"2001","unstructured":"Campisi J . Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 2001; 11: S27\u2013S31.","journal-title":"Trends Cell Biol"},{"key":"BFonc2013249_CR47","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1349-7006.2003.tb01382.x","volume":"94","author":"F Ishikawa","year":"2003","unstructured":"Ishikawa F . Cellular senescence, an unpopular yet trustworthy tumor suppressor mechanism. Cancer Sci 2003; 94: 944\u2013947.","journal-title":"Cancer Sci"},{"key":"BFonc2013249_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3835(01)00847-3","volume":"179","author":"IB Roninson","year":"2002","unstructured":"Roninson IB . Oncogenic functions of tumour suppressor p21(Waf1\/Cip1\/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 2002; 179: 1\u201314.","journal-title":"Cancer Lett"},{"key":"BFonc2013249_CR49","first-page":"3242","volume":"54","author":"RK Singh","year":"1994","unstructured":"Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ . Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994; 54: 3242\u20133247.","journal-title":"Cancer Res"},{"key":"BFonc2013249_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1476-4598-8-57","volume":"8","author":"RK Singh","year":"2009","unstructured":"Singh RK, Lokeshwar BL . Depletion of intrinsic expression of interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs. Mol Cancer 2009; 8: 57.","journal-title":"Mol Cancer"},{"key":"BFonc2013249_CR51","first-page":"843","volume":"15","author":"RK Singh","year":"2000","unstructured":"Singh RK, Varney ML . IL-8 expression in malignant melanoma: implications in growth and metastasis. Histol Histopathol 2000; 15: 843\u2013849.","journal-title":"Histol Histopathol"},{"key":"BFonc2013249_CR52","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1158\/0008-5472.CAN-09-4442","volume":"70","author":"SJ Huh","year":"2010","unstructured":"Huh SJ, Liang S, Sharma A, Dong C, Robertson GP . Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res 2010; 70: 6071\u20136082.","journal-title":"Cancer Res"},{"key":"BFonc2013249_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1083\/jcb.200408130","volume":"167","author":"S Weis","year":"2004","unstructured":"Weis S, Cui J, Barnes L, Cheresh D . Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 2004; 167: 223\u2013229.","journal-title":"J Cell Biol"},{"key":"BFonc2013249_CR54","doi-asserted-by":"publisher","first-page":"7638","DOI":"10.1158\/0008-5472.CAN-07-6614","volume":"68","author":"MA Tran","year":"2008","unstructured":"Tran MA, Gowda R, Sharma A, Park EJ, Adair J, Kester M et al. Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development. Cancer Res 2008; 68: 7638\u20137649.","journal-title":"Cancer Res"},{"key":"BFonc2013249_CR55","doi-asserted-by":"publisher","first-page":"8200","DOI":"10.1158\/0008-5472.CAN-06-0809","volume":"66","author":"A Sharma","year":"2006","unstructured":"Sharma A, Tran MA, Liang S, Sharma AK, Amin S, Smith CD et al. Targeting mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases. Cancer Res 2006; 66: 8200\u20138209.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2013249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013249","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:15:50Z","timestamp":1647890150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2013249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,22]]},"references-count":55,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2014,5,29]]}},"alternative-id":["BFonc2013249"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.249","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,22]]},"assertion":[{"value":"22 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}